H-D-Arg(Pmc)-OH is a protected amino acid derivative based on L-arginine, where the side-chain guanidinium functionality is masked as a Pmc (2,2,5,7,8-pentamethylchroman-6-sulfonyl) protecting group and the molecule bears a free alpha-amino group and a free carboxylic acid. The arginine backbone contains the alpha-amino and carboxyl groups required for peptide coupling chemistry, while the Pmc group provides steric and electronic shielding of the guanidinium, supporting chemoselective handling during stepwise synthesis. In peptide synthesis and chemical biology workflows, H-D-Arg(Pmc)-OH is used as a protected arginine building block to control side-chain reactivity and to introduce a protected arginine residue into larger peptide or peptide-like structures for subsequent deprotection and downstream conjugation or labeling.
H-D-Arg(Pmc)-OH is a protected D-arginine derivative in which the α-amino group is present as the free amino acid while the guanidinium side chain is masked with a Pmc (2,2,5,7,8-pentamethylchroman-6-sulfonyl) protecting group. The molecule retains the stereogenic α-carbon characteristic of D-arginine, providing defined chiral recognition during peptide coupling and downstream transformations. The Pmc-protected guanidine strongly modulates basicity and nucleophilicity, enabling controlled peptide bond formation without side-chain interference. As an amino acid building block, H-D-Arg(Pmc)-OH functions as a chiral intermediate for protected amino acid synthesis, where selective deprotection can regenerate the guanidinium functionality for electrostatic interactions in peptide and peptidomimetic contexts.
1. Peptide Synthesis
H-D-Arg(Pmc)-OH is used in peptide synthesis workflows where D-arginine incorporation is required for stereochemical control of peptide conformation and binding. The protected guanidine, carried by the Arg side chain, reduces undesired side reactions during standard amide coupling while maintaining a defined residue identity for sequence assembly. Pmc protection supports orthogonal handling relative to other side-chain protecting groups, allowing iterative protection strategies across multi-residue constructs. Downstream deprotection can restore the guanidinium group to enable salt-bridge formation and strong hydrogen-bonding motifs in the final peptide architecture, supporting research-grade peptide building block preparation and analog construction.
2. Chemical Biology
H-D-Arg(Pmc)-OH is relevant to chemical biology applications that require guanidinium-bearing motifs with controlled stereochemistry for molecular recognition studies. The D-configuration at the α-carbon can be leveraged to probe stereochemical effects on cell-surface binding, receptor-like interactions, and protease resistance patterns in peptide analogs. The Pmc-protected side chain enables incorporation into peptide conjugates without premature cationic behavior that could complicate synthesis or purification. Following controlled deprotection, the regenerated guanidinium functionality can be used to drive electrostatic interactions in biomolecule-binding probes, enabling amino acid derivatization strategies that map structure-function relationships.
3. Bioconjugation Chemistry
H-D-Arg(Pmc)-OH can be applied to bioconjugation chemistry where arginine-derived cationic handles are introduced into peptide linkers or targeting segments. The amino acid framework supports coupling to activated carboxyl or amine partners, while the Pmc group provides a temporary suppression of guanidinium reactivity during conjugate assembly. Selective deprotection can then expose the guanidinium group to enhance aqueous-phase interaction with negatively charged biomolecular surfaces, such as nucleic acids or membrane components, depending on the conjugate design. The resulting D-arginine-containing conjugates serve as intermediates for downstream functional molecule generation in applied biochemical research and materials-oriented labeling schemes.
4. Peptidomimetics And SAR
H-D-Arg(Pmc)-OH is suitable for peptidomimetic construction and structure-activity relationship (SAR) studies that examine how stereochemistry and side-chain charge distribution influence binding. The Pmc-protected guanidine allows systematic incorporation of a D-arginine residue into peptide-like scaffolds while keeping side-chain functionality masked during synthetic diversification. The ability to regenerate the guanidinium group after assembly supports iterative modification of charged pharmacophore elements, including linker length changes and neighboring residue substitutions. The chiral amino acid intermediate nature of H-D-Arg(Pmc)-OH supports fragment-based molecular design and SAR library synthesis where controlled deprotection yields consistent functional group presentation across analogs.
5. Pharmaceutical Intermediate Preparation
H-D-Arg(Pmc)-OH is used as a protected amino acid intermediate in pharmaceutical manufacturing-oriented synthesis planning for sequence-defined peptidic or peptidomimetic intermediates. The Pmc-protected guanidine provides a manufacturing-compatible strategy to manage strong basicity and potential side reactions during coupling steps, while the defined D-stereochemistry supports reproducible chiral residue incorporation. The amino acid form supports conversion into activated derivatives for controlled peptide bond formation, and the orthogonality of the protecting group can be integrated into protecting-group choreography across complex sequences. Downstream deprotection yields a guanidinium-bearing residue aligned with peptide science requirements for electrostatic functionality, enabling industrial fine chemical synthesis of protected peptide building blocks and their subsequent transformation into final structured intermediates.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More